All Work

Chris Lange

How Amazon Is Breaking Into the Hotel Business

Amazon.com is further expanding its empire with its latest partnership to put its virtual assistant in Marriott hotel rooms. Amazon’s Echo smart speakers will be added in select rooms in the hotel chain.

Chris Lange · 8 years ago

Why Sarepta Shares Are Skyrocketing

Sarepta Therapeutics shares skyrocketed on Tuesday after the firm presented positive preliminary results from its midstage Duchenne muscular dystrophy trial.

Chris Lange · 8 years ago

Will SurveyMonkey Be the Next Big Confidential IPO?

SurveyMonkey announced that its parent company, SVMK, has submitted a draft registration statement with the SEC for its initial public offering. This is a confidential filing.

Chris Lange · 8 years ago

Monday’s Biggest Winners and Losers in the S&P 500

Monday was a down day for the broad U.S. markets. The Nasdaq took another day off from hitting more all-time highs. Crude oil recovered slightly in Friday’s session and is back just above $65.…

Chris Lange · 8 years ago

Forty Seven Announces Potential Pricing for IPO

Clinical-stage immuno-oncology company Forty Seven intends to price more than 6 million shares so that the entire offering is valued up to more than $123 million.

Chris Lange · 8 years ago

Why PTC Therapeutics Shares Are Booming

PTC Therapeutics watched its shares make a massive gain early on Monday after the firm presented updated preliminary results from its study investigating risdiplam in babies with spinal muscular atrophy.

Chris Lange · 8 years ago

FDA Lifts Clinical Hold on Solid Biosciences

Solid Biosciences watched its shares surge to kick off the week after the FDA lifted the clinical hold on its treatment for Duchenne muscular dystrophy.

Chris Lange · 8 years ago

Oracle, Micron, FedEx and More Earnings Coming This Week

The U.S. markets didn’t gain much traction this past week with the exception of the Nasdaq hitting new all-time highs. Although most companies already have reported earnings and the main part of earnings season…

Chris Lange · 8 years ago

Neon Therapeutics Closes in on IPO

Neon Therapeutics filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. The company intends to price its 6.25 million shares in the range of $15…

Chris Lange · 8 years ago

Kellogg Issues Recall For Honey Smacks Cereal

Kellogg Co. (NYSE: K) announced on Thursday that it would be recalling roughly 1.3 million cases of its Honey Smack cereal due to a the potential for Salmonella contamination. The U.S. Food & Drug…

Chris Lange · 8 years ago

Affimed Sinks Despite Positive Interim Results

Affimed N.V. (NASDAQ: AFMD) shares dropped sharply early on Friday after the firm released new results from its early stage trial with Keytruda. The firm presented new interim data from the Phase 1b dose…

Chris Lange · 8 years ago

Record Revenue Not Enough to Pull Up Adobe

Adobe Systems Inc. (NASDAQ: ADBE) released its fiscal second quarter financial results after the markets closed on Thursday. The company said that it had $1.66 in earnings per share (EPS) and $2.20 billion in…

Chris Lange · 8 years ago

Thursday’s Biggest Winners and Losers in the S&P 500

Thursday was a positive day for the broad U.S. markets. Again, the Nasdaq hit an all-time high in the session reaching closer to 7,800. The S&P 500 is still holding just below the 2,800…

Chris Lange · 8 years ago

American Express Busts Out New Cash Back Card

American Express announced that it is launching a new cash-back card that offers users even greater flexibility. The card is expected to gain some traction among millennial spenders who simply want a way to…

Chris Lange · 8 years ago

Why Nightstar Is Thursday’s Top Biotech

Nightstar Therapeutics PLC (NASDAQ: NITE) shares saw a massive gain on Thursday after the firm announced a crucial decision from the U.S. Food and Drug Administration (FDA). Essentially, the agency has granted Regenerative Medicine…

Chris Lange · 8 years ago